Articles About NYSE:MRK
June 16, 2014
Merck stock been surging higher over the last couple of quarters and is currently trading near highs for the year.
June 13, 2014
Last week, Merck shelled out nearly $4 billion to purchase Idenix and its experimental drug pipeline. Was the purchase a calculated risk or a desperate move?